Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC): study protocol for a prospective trial - Coutu, Brendan; Lawrence, Elliot; Ganti, Apar Kishor; Marr, Alissa; Wichman, Chris; Zhang, Chi (Journal of Thoracic Disease; Vol 16, No 1 (January 30, 2024): Journal of Thoracic Disease, 2024)